重复立体定向放疗治疗脑转移患者特征的变化:184例患者的回顾性研究
该回顾性研究分析了2010至2020年间至少接受两次立体定向放疗(SRT)且未先行全脑放疗的184例脑转移患者,共治疗915个脑转移灶。结果显示各次SRT间WHO、Ds-GPA和RPA稳定,KPS在首次SRT时显著优于后续SRT,首次SRT时脑转移灶最大且手术更多;结论认为重复SRT未导致一般状况明显恶化,低级别脑转移速度患者可预期较长生存,不应放弃全脑放疗。
要点
- 184例患者接受2至6次SRT,共治疗915个脑转移灶,每次SRT中位治疗1个病灶。
- 各次SRT间WHO、Ds-GPA和RPA稳定,KPS在首次SRT时显著优于后续SRT。
- 末次SRT时脑转移速度高、中、低级别患者分别占6.5%、37.5%和56%。
核心结论
- 重复SRT未导致一般状况明显恶化,所有SRT期间超过95%的患者KPS维持在70%以上。
- 低级别脑转移速度患者可预期较长生存。
- 不应放弃全脑放疗,尤其是对于每年新发超过12个脑转移灶的患者。
研究设计与样本
- 回顾性研究,纳入2010至2020年间至少接受两次SRT且未先行全脑放疗的184例脑转移患者。
- 记录年龄、WHO体能状态、KPS、颅外进展、全身治疗类型和脑转移灶数目,并计算RPA、Ds-GPA和脑转移速度。
主要发现
- 184例患者共治疗915个脑转移灶,接受2至6次SRT用于局部或远处脑复发。
- 每次SRT中位治疗1个脑转移灶(范围1-6),所有疗程中位治疗4个脑转移灶(范围2-19)。
- WHO、Ds-GPA和RPA在各次SRT间稳定,KPS在首次SRT时显著优于后续SRT。
- 各次SRT间脑转移灶数目无显著差异,但首次SRT时脑转移灶有更多趋势(p=0.06)。
- 首次SRT时患者脑转移灶最大且接受更多手术(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Brain metastases (BMs) are the leading cause of intracranial malignant neoplasms in adults. WHO, Karnofsky performance status (KPS), age, number of BMs, extracerebral progression (ECP), recursive partitioning analysis (RPA), diagnosis-specific graded prognostic assessment (Ds-GPA) are validated prognostic tools to help clinicians decide on treatment. No consensus exists for repeat stereotactic radiotherapy (SRT) for BMs. The aim of this study was to review the changes in patient characteristics treated with repeated SRTs. METHODS AND MATERIALS: The data of patients treated between 2010 and 2020 with at least two courses of SRT without previous whole brain radiotherapy (WBRT) were reviewed. Age, WHO, KPS, ECP, type of systemic treatment, number of BMs were recorded. RPA, Ds-GPA and brain metastasis velocity (BMV) were calculated. RESULTS: 184 patients were treated for 915 BMs and received two to six SRTs for local or distant brain recurrence. The median number of BMs treated per SRT was 1 (range: 1-6), for a median of 4 BMs treated during all sessions (range: 2-19). WHO, Ds-GPA and RPA were stable between each session of SRT, whereas KPS was significantly better in SRT1 than in the following SRT. The number of BMs was not significantly different between each SRT, but there was a tendency for more BM at SRT1 (p = 0.06). At SRT1, patients had largest BM and undergo more surgery than during the following SRT (p < 0.001). 6.5%, 37.5% and 56% of patients were classified as high, intermediate, and low BMV, respectively, at the last SRT session. There was almost perfect concordance between the BMV-grade calculated at the last SRT session and at SRT2 (r = 0.89; p < 0.001). CONCLUSION: Repeated SRT doesn't lead to a marked alteration in the general condition, KPS was maintained at over 70% for more than 95% of patients during all SRTs. Long survival can be expected, especially in low-grade BMV patients. WBRT shouldn't be aborted, especially for patients developing more than twelve BMs annually.
引用
- Kuntz L, Le Fèvre C, Jarnet D, et al. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients. Radiat Oncol. 2023. PMID: 36717863. doi:10.1186/s13014-023-02200-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。